{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:51:01Z","timestamp":1770753061381,"version":"3.50.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cryptococcal meningitis (CM) is a common HIV-associated opportunistic-infection worldwide. Existing literature focusses on hospital-based outcomes of induction treatment. This paper reviews outpatient management in integrated primary care clinics in Yangon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This retrospective case note review analyses a Myanmar HIV-positive patient cohort managed using ambulatory induction-phase treatment with intravenous amphotericin-B-deoxycholate (0.7\u20131.0\u2009mg\/kg) and oral fluconazole (800\u2009mg orally\/day).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventy-six patients were diagnosed between 2010 and 2017. The median age of patients diagnosed was 35\u2009years, 63% were male and 33 (45%) were on concurrent treatment for tuberculosis. The median CD4 count was 60 at the time of diagnosis. Amphotericin-B-deoxycholate infusions precipitated 56 episodes of toxicity, namely hypokalaemia, nephrotoxicity, anaemia, febrile reactions, phlebitis, observed in 44 patients (58%). One-year survival (86%) was higher than existing hospital-based treatment studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Ambulation of patients in this cohort saved 1029 hospital bed days and had better survival outcomes when compared to hospital-based studies in other resource constrained settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06049-z","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T10:11:12Z","timestamp":1618999872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-0986","authenticated-orcid":false,"given":"Clare E.","family":"Warrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair R. D.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Smithuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni Ni","family":"Tun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"issue":"8","key":"6049_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873\u201381. https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8.","journal-title":"Lancet Infect Dis"},{"key":"6049_CR2","unstructured":"UNAIDS website: https:\/\/www.unaids.org\/en\/regionscountries.countries\/myanmar. (Accessed 22.09.20)."},{"key":"6049_CR3","unstructured":"World Health Organization [WHO] Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018. Geneva. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"6049_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12281-011-0082-6","volume":"6","author":"M Vanselow","year":"2012","unstructured":"Vanselow M, Brandt ME, Park BJ. Diagnosis and Management of Cryptococcal Disease in resource-limited settings. Curr Fungal Infect Rep. 2012;6(1):35\u201340. https:\/\/doi.org\/10.1007\/s12281-011-0082-6.","journal-title":"Curr Fungal Infect Rep"},{"issue":"7","key":"6049_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004865","volume":"10","author":"S Meiring","year":"2016","unstructured":"Meiring S, Fortuin-de Smidt M, Kularatne R, Dawood H, Govender NP, GERMS-SA. GERMS-SA prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during treatment of HIV-associated Cryptococcal meningitis in South Africa. PLoS Negl Trop Dis. 2016;10(7):e0004865. https:\/\/doi.org\/10.1371\/journal.pntd.0004865.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"6049_CR6","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1128\/AAC.01698-15","volume":"59","author":"T Bicanic","year":"2015","unstructured":"Bicanic T, Bottomley C, Loyse A, Brouwer AE, Muzoora C, Taseera K, et al. Toxicity of amphotericin B Deoxycholate-based induction therapy in patients with HIV-associated Cryptococcal meningitis. Antimicrob Agents Chemother. 2015;59(12):7224\u201331. https:\/\/doi.org\/10.1128\/AAC.01698-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"6049_CR7","doi-asserted-by":"publisher","first-page":"ofu070","DOI":"10.1093\/ofid\/ofu070","volume":"1","author":"NC Bahr","year":"2014","unstructured":"Bahr NC, Rolfes MA, Musubire A, Nabeta, et al. Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings. Open Forum Infect Dis. 2014;1(2):ofu070.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"6049_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1086\/520665","volume":"45","author":"S Sundar","year":"2007","unstructured":"Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, et al. Amphotericin B treatment for Indian visceral Leishmaniasis: response to 15 daily versus alternate-day infusions. Clin Infect Dis. 2007;45(5):556\u201361. https:\/\/doi.org\/10.1086\/520665.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"6049_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/hiv.12886","volume":"21","author":"NN Tun","year":"2020","unstructured":"Tun NN, McLean ARD, Wilkins E, Hlaing MMM, Aung YY, Linn T, et al. Integration of HIV services with primary are in Yangon, Myanmar: a retrospective cohort analysis. HIV Med. 2020;21(9):547\u201356. https:\/\/doi.org\/10.1111\/hiv.12886.","journal-title":"HIV Med"},{"key":"6049_CR10","unstructured":"M\u00e9decins Sans Fronti\u00e8res. MSF HIV\/TB Clinical Guide. 8th ed. Abrahams M, editor. Cape Town: M\u00e9decins Sans Fronti\u00e8res; 2015 guidelines."},{"key":"6049_CR11","unstructured":"Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events. Corrected Version 2.1 July 2017 Division of AIDS National Institute of Allergy and Infectious Diseases National Institutes of Health US Department of Health and Human Service."},{"key":"6049_CR12","unstructured":"World Health Organization [WHO] Estimates of Unit Costs for Patient Services for Myanmar https:\/\/www.who.int\/choice\/country\/mmr\/cost\/en\/ (Accessed on 22\/09\/2020)."},{"issue":"5","key":"6049_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736\u201345. https:\/\/doi.org\/10.1093\/cid\/cit794.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"6049_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/516298","volume":"26","author":"RS Heyderman","year":"1998","unstructured":"Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, Musvaire P, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis. 1998;26(2):284\u20139. https:\/\/doi.org\/10.1086\/516298.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"6049_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","volume":"378","author":"SF Molloy","year":"2018","unstructured":"Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, et al. ACTA trial study team. Antifungal combinations for treatment of cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1710922.","journal-title":"N Engl J Med"},{"issue":"3","key":"6049_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/cid\/ciz454","volume":"70","author":"C Kanyama","year":"2020","unstructured":"Kanyama C, Molloy SF, Chan AK, Lupiya D, Chawinga C, Adams J, et al. One-year mortality outcomes from the advancing Cryptococcal meningitis treatment for Africa trial of Cryptococcal meningitis treatment in Malawi. Clin Infect Dis. 2020;70(3):521\u20134. https:\/\/doi.org\/10.1093\/cid\/ciz454.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6049_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s13063-018-3026-4","volume":"19","author":"DS Lawrence","year":"2018","unstructured":"Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, et al. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial. Trials. 2018;19(1):649. https:\/\/doi.org\/10.1186\/s13063-018-3026-4.","journal-title":"Trials"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06049-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T10:14:10Z","timestamp":1619000050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06049-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6049"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06049-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was a service review therefore it was deemed exempt from ethics review in accordance with Oxford Tropical Research Ethics Committee guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"375"}}